Exploring the role of multi-pathogen infections in Alzheimer's disease: A case-control study

Victor Garcia-Bustos1,2,3, Marta Dafne Cabanero-Navalon4,5, Carmen Lloret-Sos6

  • 1Severe Infection Research Group, Health Research Institute La Fe, Valencia, Spain.

Virulence
|September 13, 2025
PubMed
Abstract

Insights

Infections by cytomegalovirus (CMV), Chlamydia pneumoniae, and Coxiella burnetii may contribute to Alzheimer's disease (AD) development and progression. Higher infection burden correlated with faster disease advancement and poorer cognitive function in AD patients.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Gerontology

Background:

  • Alzheimer's disease (AD) is a major cause of dementia, with emerging research exploring infectious agents' roles.
  • The amyloid hypothesis's link to antimicrobial properties has spurred investigation into pathogens as AD contributors.
  • This study examines the impact of multi-pathogen infections on AD by analyzing microbial markers.

Purpose of the Study:

  • To investigate the association between specific pathogens and Alzheimer's disease.
  • To identify predictors of AD and disease progression based on infectious markers.
  • To explore the role of latent infections in AD pathophysiology.

Main Methods:

  • A case-control study involving 44 AD patients and 35 healthy controls.
  • Analysis of serum and cerebrospinal fluid (CSF) for serological and molecular microbial markers.
  • Multivariable logistic regression with bootstrap validation to identify independent predictors of AD.

Main Results:

  • Significantly higher seropositivity for human cytomegalovirus (HCMV) and Coxiella burnetii in AD patients.
  • HCMV, Chlamydia pneumoniae, and age identified as independent predictors of AD.
  • Triple infections (HCMV, C. pneumoniae, C. burnetii) linked to faster progression and poorer cognitive/CSF biomarkers.

Conclusions:

  • Latent infections with HCMV, C. pneumoniae, and C. burnetii may play a role in AD pathophysiology.
  • Infectious burden could influence AD through systemic or immune-mediated pathways.
  • Further research is necessary to confirm these findings and elucidate the role of infections in AD.